Dopamine D1 receptor-dependent regulation of extracellular citrulline level in the rat nucleus accumbens during conditioned fear response

Neurosci Lett. 2008 Aug 1;440(2):185-9. doi: 10.1016/j.neulet.2008.05.062. Epub 2008 May 22.

Abstract

Nucleus accumbens (N.Acc) contains a subclass of nitric oxide (NO)-generating interneurons that are presumably regulated by the dopamine input. Receptor mechanisms underlying dopamine-NO interaction in the N.Acc are poorly understood. In the current study, we used in vivo microdialysis combined with high-performance liquid chromatography to examine participation of dopamine D1 receptors in regulation of extracellular levels of citrulline (an NO co-product) in the medial N.Acc of Sprague-Dawley rats during both pharmacological challenge and a conditioned fear response. The intraaccumbal infusion of the D1 receptor agonist SKF-38393 (100-500 microM) increased dose-dependently the local dialysate citrulline levels. The SKF-38393-induced increase in extracellular citrulline was prevented by intraaccumbal infusions of 500 microM 7-nitroindazole, a neuronal NO synthase inhibitor. In behavioral microdialysis experiment, the accumbal levels of extracellular citrulline markedly increased in rats given a mild footshock paired with tone. The presentation of the tone previously paired with footshock (the conditioned fear response) produced a "conditioned" rise of extracellular citrulline levels in the N.Acc which was attenuated by intraaccumbal infusion of 100 microM SCH-23390, a dopamine D1 receptor antagonist, and prevented by intraaccumbal infusion of 500 microM 7-nitroindazole. The results suggest that in the N.Acc, the dopamine D1 receptors might regulate the neuronal NO synthase activity; this dopamine-dependent mechanism seems to participate in activation of the neuronal NO synthase and probably NO formation in this brain area during the conditioned fear response.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / administration & dosage
  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / pharmacology
  • Animals
  • Behavior, Animal / drug effects
  • Behavior, Animal / physiology
  • Benzazepines / administration & dosage
  • Benzazepines / pharmacology
  • Chromatography, High Pressure Liquid
  • Citrulline / analysis
  • Citrulline / metabolism*
  • Conditioning, Classical / drug effects
  • Conditioning, Classical / physiology
  • Dopamine Agonists / administration & dosage
  • Dopamine Agonists / pharmacology
  • Dopamine Antagonists / administration & dosage
  • Dopamine Antagonists / pharmacology
  • Dose-Response Relationship, Drug
  • Emotions / drug effects
  • Emotions / physiology
  • Enzyme Inhibitors / administration & dosage
  • Enzyme Inhibitors / pharmacology
  • Extracellular Space / drug effects
  • Extracellular Space / metabolism
  • Fear / drug effects
  • Fear / psychology*
  • Indazoles / administration & dosage
  • Indazoles / pharmacology
  • Male
  • Microdialysis / methods
  • Nucleus Accumbens / drug effects
  • Nucleus Accumbens / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Dopamine D1 / metabolism*

Substances

  • Benzazepines
  • Dopamine Agonists
  • Dopamine Antagonists
  • Enzyme Inhibitors
  • Indazoles
  • Receptors, Dopamine D1
  • Citrulline
  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
  • 7-nitroindazole